Literature DB >> 32125792

RESCUE-AF in Patients Undergoing Atrial Fibrillation Ablation: The RESCUE-AF Trial

Xi Zhang1, Xiaohui Kuang1, Xiaolong Gao1, Hong Xiang1, Feiyu Wei1, Tong Liu2, Haiyan Wu1, Gang Wang3, Zan Zuo4, Lilin Wang1, Liqun Ding1, Jin Zhang1, Michael Shehata5, Xunzhang Wang5, Bing Yang6, Jie Fan1.   

Abstract

BACKGROUND: Although contact force (CF)–sensing catheters improve procedural effectiveness and safety of atrial fibrillation ablation, recent reports documented a higher incidence of atrioesophageal fistula formation relative to ablation with non–CF-sensing catheters.The present study was to assess whether restricting CF to <20 g reduced risk for esophageal injury (EI) in patients with atrial fibrillation undergoing circumferential pulmonary vein isolation.
METHODS: This prospective, single-center, randomized study enrolled 89 consecutive patients (mean age, 57.2±11.3 years; 57.3% men) with atrial fibrillation (68.5% paroxysmal and 31.5% persistent). Computed tomography angiography, transesophageal echocardiography, and esophageal endoscopy were conducted before the procedure, and a repeat esophageal endoscopy was performed after the procedure. Patients were randomized to restricted-CF group (n=44) or non-CF group (n=45), with circumferential pulmonary vein isolation using a CF-sensing (CF restricted to <20 g) or non–CF-sensing catheter, respectively. The primary end point was rate of EI post ablation.
RESULTS: Baseline characteristics were evenly distributed between groups, without a case of preprocedural EI. With the same power setting, similar ablation time and average measured catheter tip temperature during posterior wall ablation just opposite to the esophagus in all patients in the restricted-CF group versus non-CF groups, there were no cases versus 9 (20%) cases of EI post ablation, respectively, with similar rate of freedom from atrial tachyarrhythmias at mean 31.3±6.5 months follow-up (68.2% versus 64.4%; P=0.3798).
CONCLUSIONS: Risk for EI was minimized when CF was restricted to <20 g at the posterior left atrial wall, where the circumferential pulmonary vein isolation lesion set and the course of the esophagus overlapped in all subjects.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; fistula; incidence; pulmonary veins

Year:  2019        PMID: 32125792     DOI: 10.1161/CIRCEP.118.007044

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  5 in total

1.  Relationship between the posterior atrial wall and the esophagus: esophageal position and temperature measurement during atrial fibrillation ablation (AWESOME-AF). A randomized controlled trial.

Authors:  Cheryl Teres; David Soto-Iglesias; Diego Penela; Giulio Falasconi; Daniel Viveros; Julia Meca-Santamaria; Aldo Bellido; Jose Alderete; Alfredo Chauca; Augusto Ordoñez; Julio Martí-Almor; Claudia Scherer; Alejandro Panaro; Julio Carballo; Óscar Cámara; Jose-Tomás Ortiz-Pérez; Antonio Berruezo
Journal:  J Interv Card Electrophysiol       Date:  2022-07-21       Impact factor: 1.759

2.  Preventing esophageal complications from atrial fibrillation ablation: A review.

Authors:  Lisa W M Leung; Zaki Akhtar; Mary N Sheppard; John Louis-Auguste; Jamal Hayat; Mark M Gallagher
Journal:  Heart Rhythm O2       Date:  2021-09-22

Review 3.  Efficacy and safety of same-day discharge after atrial fibrillation ablation: A systematic review and meta-analysis.

Authors:  Sina Rashedi; Hamed Tavolinejad; Sina Kazemian; Mahta Mardani; Maryam Masoudi; Farzad Masoudkabir; Majid Haghjoo
Journal:  Clin Cardiol       Date:  2022-01-27       Impact factor: 2.882

Review 4.  Protecting Against Collateral Damage to Non-cardiac Structures During Endocardial Ablation for Persistent Atrial Fibrillation.

Authors:  Lisa Wm Leung; Zaki Akhtar; Jamal Hayat; Mark M Gallagher
Journal:  Arrhythm Electrophysiol Rev       Date:  2022-04

5.  Randomized comparison of oesophageal protection with a temperature control device: results of the IMPACT study.

Authors:  Lisa W M Leung; Abhay Bajpai; Zia Zuberi; Anthony Li; Mark Norman; Riyaz A Kaba; Zaki Akhtar; Banu Evranos; Hanney Gonna; Idris Harding; Manav Sohal; Nawaf Al-Subaie; John Louis-Auguste; Jamal Hayat; Mark M Gallagher
Journal:  Europace       Date:  2021-02-05       Impact factor: 5.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.